Given that 5hmC has been suggested as a highly specific marker of lineage commitment during tissue development, and that prostate cancer can undergo lineage plasticity to escape AR-directed therapy (53), we next sought to evaluate 5hmC tissue specific markers in prostate cancer. The gene discussed is AR; the disease is Familial prostate cancer.